NASA’s SpaceX Crew-12 Launches to International Space Station

NASA’s SpaceX Crew-12 mission successfully launched to the International Space Station, marking another milestone in commercial crew collaboration. The crew aboard the SpaceX Dragon spacecraft will conduct scientific research, technology demonstrations, and maintenance operations during their stay in orbit. Officials highlighted the mission’s role in advancing space exploration and international cooperation. The launch reinforces ongoing partnerships supporting sustained human presence in low Earth orbit.

Cantor Fitzgerald has raised its price target for Vertex Pharmaceuticals to $590, citing strong potential in the company’s expanding renal disease franchise. Analysts highlighted promising pipeline developments and long-term revenue growth opportunities driven by innovative therapies. The upgraded outlook reflects confidence in Vertex’s strategic positioning within specialty pharmaceuticals. Investors responded positively as the revised target underscores optimism around sustained earnings expansion.